These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 14436181)

  • 21. Serum glutamic oxalacetic transaminase in myocardial infarction; its diagnostic and prognostic value.
    HANSEN PF; LAURSEN T
    Dan Med Bull; 1957 Dec; 4(8):248-51. PubMed ID: 13500846
    [No Abstract]   [Full Text] [Related]  

  • 22. Serum glutamic-oxalacetic transaminase activity in conditions associated with myocardial infarction. II. Cerebral vascular accidents and congestive heart failure.
    LIEBERMAN J; LASKY II; DULKIN SI; LOBSTEIN OE
    Ann Intern Med; 1957 Mar; 46(3):497-505. PubMed ID: 13403533
    [No Abstract]   [Full Text] [Related]  

  • 23. [Glutamic-oxalacetic transaminases and lactic dehydrogenases in myocardial infarct].
    RULLI V; CONCINA B
    Cuore Circ; 1960 Jun; 44():156-68. PubMed ID: 14440168
    [No Abstract]   [Full Text] [Related]  

  • 24. Glutamic oxalacetic transaminase and C-reactive protein in myocardial infarction, with special reference to the electrocardiographic pattern.
    BURSTEIN J; HARJANNE A
    Acta Med Scand; 1959 Mar; 163(3):175-84. PubMed ID: 13636816
    [No Abstract]   [Full Text] [Related]  

  • 25. The significance of the serum glutamic oxalacetic transaminase activity following acute myocardial infarction.
    LADUE JS; WROBLEWSKI F
    Circulation; 1955 Jun; 11(6):871-7. PubMed ID: 14379421
    [No Abstract]   [Full Text] [Related]  

  • 26. [Determination of serum glutamic oxalic acid transaminase in myocardial infarct].
    KERTESZ T; KREMMER T; ROTTER L; FERENCZY E
    Orv Hetil; 1960 Nov; 101():1596-9. PubMed ID: 13752709
    [No Abstract]   [Full Text] [Related]  

  • 27. Differences in the distribution of glutamic acid-oxalacetic acid transaminase- and aldolase-activity among serum protein fractions in patients with acute myocardial infarct and hepatocellular damage.
    TENYI M; VARGA L; KOVACS I; LEHOTAY L
    Med Exp Int J Exp Med; 1961; 4():335-40. PubMed ID: 13920250
    [No Abstract]   [Full Text] [Related]  

  • 28. The serum glutamic oxalacetic transaminase determination: its clinical use in the diagnosis of myocardial infarction and in the differential diagnosis of chest pains.
    SELIGSON D; ZINGESSER LH; GOLDSTEIN F
    Pa Med J; 1957 Jun; 60(6):728-34. PubMed ID: 13431381
    [No Abstract]   [Full Text] [Related]  

  • 29. Serum glutamic-oxalacetic transaminase in acute myocardial infarction.
    RUDOLPH LA; LINDEMAN R; LYONS RH
    N Y State J Med; 1958 Aug; 58(15):2520-4. PubMed ID: 13566531
    [No Abstract]   [Full Text] [Related]  

  • 30. Glutamic oxalacetic transaminases in the diagnosis of acute myocardial infarct.
    BERCONSKY I; LIPPENHOLTZ A; NIJENSOHN CM; LIPPENHOLTZ L
    Prensa Med Argent; 1957 Jul; 44(28):2147-57. PubMed ID: 13505514
    [No Abstract]   [Full Text] [Related]  

  • 31. [Significance of the determination of glutamic-oxalic transaminase in the diagnosis and differential diagnosis of acute myocardial infarction].
    BAGROV IaIu
    Sov Med; 1961 Oct; 25():3-11. PubMed ID: 13863946
    [No Abstract]   [Full Text] [Related]  

  • 32. [Contribution to the diagnosis of myocardial infarct. Note 2. The determination of glutamic-oxalacetic transaminase and lactic dehydrogenase in acute myocardial infarct].
    FONNESU V; MARTINELLI M; SILVESTRI G
    Riforma Med; 1960 May; 74():543-8. PubMed ID: 13700583
    [No Abstract]   [Full Text] [Related]  

  • 33. [Blood transaminases in cardiovascular pathology; value of the simultaneous determination of blood glutamic oxalacetic & glutamic pyruvic transaminases].
    BRUYET P; BENEVENT J; LYON D; ISORNI P; DELAUNAY A; MEIGNIEN C
    Arch Mal Coeur Vaiss; 1958 Aug; 51(8):758-71. PubMed ID: 13572135
    [No Abstract]   [Full Text] [Related]  

  • 34. Serum glutamic oxalacetic-transaminase activity in the diagnosis of myocardial infarction and hepatic necrosis.
    WALTERS MN; LITTLEJOHN PG
    Med J Aust; 1958 Jan; 45(3):76-80. PubMed ID: 13503423
    [No Abstract]   [Full Text] [Related]  

  • 35. Glutamic-oxalacetic transaminase in the diagnosis of myocardial infarction. II. Comparison of serum transaminase activity with determinations of serum aldolase, cholesterol, alpha2-globulin, iron, copper and lactic dehydrogenase.
    HANSON A; BIORCK G
    Acta Med Scand; 1957 Jun; 157(6):493-502. PubMed ID: 13434796
    [No Abstract]   [Full Text] [Related]  

  • 36. [Diagnostic value of the determination of serum glutamicoxalacetic transaminase in myocardial infarct].
    FEDELE F; FUMAGALLI E; MITTINI PA
    Minerva Cardioangiol; 1958 Apr; 6(4):231-9. PubMed ID: 13552019
    [No Abstract]   [Full Text] [Related]  

  • 37. Recent experience with the serum glutamic oxaloacetic transaminase (SGOT) as a diagnostic aid in myocardial infarction.
    SHOCHET BR
    Sinai Hosp J (Balt); 1959; 8():156-66. PubMed ID: 14446131
    [No Abstract]   [Full Text] [Related]  

  • 38. [Simultaneous determination of serum lactic dehydrogenase, glutamic-oxalacetic and glutamic-pyruvic transaminases in acute myocardial infarct].
    DECARIE L; TROCHU L; LACHAINE G; CARIGNAN P; DUMAIS B
    Union Med Can; 1960 Jul; 89():834-47. PubMed ID: 13815254
    [No Abstract]   [Full Text] [Related]  

  • 39. [Glutamic oxalacetic transaminase levels in myocardial infarction].
    VON PORAT B; HAMMARSTROM S; SWEDBERG B; KLEEN G
    Sven Lakartidn; 1957 Nov; 54(44):3309-12. PubMed ID: 13495914
    [No Abstract]   [Full Text] [Related]  

  • 40. Evaluation of the serum glutamic oxalacetic aminopherase (transaminase) test; its use in diagnosis of acute myocardial infarction.
    DENNEY JL; MCAULEY CB; MARTIN HE; WARE AG; SEGALOVE M
    J Am Med Assoc; 1956 Jun; 161(7):614-6. PubMed ID: 13318974
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.